1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cannabinoid Derived Pharmaceutical Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cannabinoid Derived Pharmaceutical by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cannabinoid Derived Pharmaceutical by Country/Region, 2018, 2022 & 2029
2.2 Cannabinoid Derived Pharmaceutical Segment by Type
2.2.1 Cannabinoid Receptor Type 1 (CB1)
2.2.2 Cannabinoid Receptor Type 2 (CB2)
2.2.3 Others
2.3 Cannabinoid Derived Pharmaceutical Sales by Type
2.3.1 Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2018-2023)
2.3.2 Global Cannabinoid Derived Pharmaceutical Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cannabinoid Derived Pharmaceutical Sale Price by Type (2018-2023)
2.4 Cannabinoid Derived Pharmaceutical Segment by Application
2.4.1 Epilepsy
2.4.2 Migraine
2.4.3 Multiple Sclerosis
2.4.4 Others
2.5 Cannabinoid Derived Pharmaceutical Sales by Application
2.5.1 Global Cannabinoid Derived Pharmaceutical Sale Market Share by Application (2018-2023)
2.5.2 Global Cannabinoid Derived Pharmaceutical Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cannabinoid Derived Pharmaceutical Sale Price by Application (2018-2023)
3 Global Cannabinoid Derived Pharmaceutical by Company
3.1 Global Cannabinoid Derived Pharmaceutical Breakdown Data by Company
3.1.1 Global Cannabinoid Derived Pharmaceutical Annual Sales by Company (2018-2023)
3.1.2 Global Cannabinoid Derived Pharmaceutical Sales Market Share by Company (2018-2023)
3.2 Global Cannabinoid Derived Pharmaceutical Annual Revenue by Company (2018-2023)
3.2.1 Global Cannabinoid Derived Pharmaceutical Revenue by Company (2018-2023)
3.2.2 Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Company (2018-2023)
3.3 Global Cannabinoid Derived Pharmaceutical Sale Price by Company
3.4 Key Manufacturers Cannabinoid Derived Pharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cannabinoid Derived Pharmaceutical Product Location Distribution
3.4.2 Players Cannabinoid Derived Pharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cannabinoid Derived Pharmaceutical by Geographic Region
4.1 World Historic Cannabinoid Derived Pharmaceutical Market Size by Geographic Region (2018-2023)
4.1.1 Global Cannabinoid Derived Pharmaceutical Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cannabinoid Derived Pharmaceutical Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cannabinoid Derived Pharmaceutical Market Size by Country/Region (2018-2023)
4.2.1 Global Cannabinoid Derived Pharmaceutical Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cannabinoid Derived Pharmaceutical Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cannabinoid Derived Pharmaceutical Sales Growth
4.4 APAC Cannabinoid Derived Pharmaceutical Sales Growth
4.5 Europe Cannabinoid Derived Pharmaceutical Sales Growth
4.6 Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Growth
5 Americas
5.1 Americas Cannabinoid Derived Pharmaceutical Sales by Country
5.1.1 Americas Cannabinoid Derived Pharmaceutical Sales by Country (2018-2023)
5.1.2 Americas Cannabinoid Derived Pharmaceutical Revenue by Country (2018-2023)
5.2 Americas Cannabinoid Derived Pharmaceutical Sales by Type
5.3 Americas Cannabinoid Derived Pharmaceutical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cannabinoid Derived Pharmaceutical Sales by Region
6.1.1 APAC Cannabinoid Derived Pharmaceutical Sales by Region (2018-2023)
6.1.2 APAC Cannabinoid Derived Pharmaceutical Revenue by Region (2018-2023)
6.2 APAC Cannabinoid Derived Pharmaceutical Sales by Type
6.3 APAC Cannabinoid Derived Pharmaceutical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cannabinoid Derived Pharmaceutical by Country
7.1.1 Europe Cannabinoid Derived Pharmaceutical Sales by Country (2018-2023)
7.1.2 Europe Cannabinoid Derived Pharmaceutical Revenue by Country (2018-2023)
7.2 Europe Cannabinoid Derived Pharmaceutical Sales by Type
7.3 Europe Cannabinoid Derived Pharmaceutical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cannabinoid Derived Pharmaceutical by Country
8.1.1 Middle East & Africa Cannabinoid Derived Pharmaceutical Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cannabinoid Derived Pharmaceutical Revenue by Country (2018-2023)
8.2 Middle East & Africa Cannabinoid Derived Pharmaceutical Sales by Type
8.3 Middle East & Africa Cannabinoid Derived Pharmaceutical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cannabinoid Derived Pharmaceutical
10.3 Manufacturing Process Analysis of Cannabinoid Derived Pharmaceutical
10.4 Industry Chain Structure of Cannabinoid Derived Pharmaceutical
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cannabinoid Derived Pharmaceutical Distributors
11.3 Cannabinoid Derived Pharmaceutical Customer
12 World Forecast Review for Cannabinoid Derived Pharmaceutical by Geographic Region
12.1 Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Region
12.1.1 Global Cannabinoid Derived Pharmaceutical Forecast by Region (2024-2029)
12.1.2 Global Cannabinoid Derived Pharmaceutical Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cannabinoid Derived Pharmaceutical Forecast by Type
12.7 Global Cannabinoid Derived Pharmaceutical Forecast by Application
13 Key Players Analysis
13.1 Cara Therapeutics Inc
13.1.1 Cara Therapeutics Inc Company Information
13.1.2 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.1.3 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cara Therapeutics Inc Main Business Overview
13.1.5 Cara Therapeutics Inc Latest Developments
13.2 Arena Pharmaceuticals
13.2.1 Arena Pharmaceuticals Company Information
13.2.2 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.2.3 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Arena Pharmaceuticals Main Business Overview
13.2.5 Arena Pharmaceuticals Latest Developments
13.3 Cannabics Pharmaceuticals Inc
13.3.1 Cannabics Pharmaceuticals Inc Company Information
13.3.2 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.3.3 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cannabics Pharmaceuticals Inc Main Business Overview
13.3.5 Cannabics Pharmaceuticals Inc Latest Developments
13.4 Echo Pharmaceuticals
13.4.1 Echo Pharmaceuticals Company Information
13.4.2 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.4.3 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Echo Pharmaceuticals Main Business Overview
13.4.5 Echo Pharmaceuticals Latest Developments
13.5 Gw Pharmaceuticals
13.5.1 Gw Pharmaceuticals Company Information
13.5.2 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.5.3 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Gw Pharmaceuticals Main Business Overview
13.5.5 Gw Pharmaceuticals Latest Developments
13.6 Inmed Pharmaceuticals
13.6.1 Inmed Pharmaceuticals Company Information
13.6.2 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.6.3 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Inmed Pharmaceuticals Main Business Overview
13.6.5 Inmed Pharmaceuticals Latest Developments
13.7 Insys Therapeutics Inc
13.7.1 Insys Therapeutics Inc Company Information
13.7.2 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.7.3 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Insys Therapeutics Inc Main Business Overview
13.7.5 Insys Therapeutics Inc Latest Developments
13.8 Larapharm
13.8.1 Larapharm Company Information
13.8.2 Larapharm Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.8.3 Larapharm Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Larapharm Main Business Overview
13.8.5 Larapharm Latest Developments
13.9 Mgc Pharmaceuticals Ltd
13.9.1 Mgc Pharmaceuticals Ltd Company Information
13.9.2 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.9.3 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mgc Pharmaceuticals Ltd Main Business Overview
13.9.5 Mgc Pharmaceuticals Ltd Latest Developments
13.10 One World Cannabis
13.10.1 One World Cannabis Company Information
13.10.2 One World Cannabis Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.10.3 One World Cannabis Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 One World Cannabis Main Business Overview
13.10.5 One World Cannabis Latest Developments
13.11 Orpheus Medica
13.11.1 Orpheus Medica Company Information
13.11.2 Orpheus Medica Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.11.3 Orpheus Medica Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Orpheus Medica Main Business Overview
13.11.5 Orpheus Medica Latest Developments
13.12 Receptor Life Sciences
13.12.1 Receptor Life Sciences Company Information
13.12.2 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.12.3 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Receptor Life Sciences Main Business Overview
13.12.5 Receptor Life Sciences Latest Developments
13.13 Respirerx Pharmaceuticals
13.13.1 Respirerx Pharmaceuticals Company Information
13.13.2 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.13.3 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Respirerx Pharmaceuticals Main Business Overview
13.13.5 Respirerx Pharmaceuticals Latest Developments
13.14 Tetra Bio-Pharma
13.14.1 Tetra Bio-Pharma Company Information
13.14.2 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.14.3 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Tetra Bio-Pharma Main Business Overview
13.14.5 Tetra Bio-Pharma Latest Developments
13.15 Cardiol Therapeutics
13.15.1 Cardiol Therapeutics Company Information
13.15.2 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.15.3 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Cardiol Therapeutics Main Business Overview
13.15.5 Cardiol Therapeutics Latest Developments
13.16 United Cannabis Corporation
13.16.1 United Cannabis Corporation Company Information
13.16.2 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.16.3 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 United Cannabis Corporation Main Business Overview
13.16.5 United Cannabis Corporation Latest Developments
13.17 Zynerba Pharmaceuticals
13.17.1 Zynerba Pharmaceuticals Company Information
13.17.2 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
13.17.3 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Zynerba Pharmaceuticals Main Business Overview
13.17.5 Zynerba Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Cannabinoid Derived Pharmaceutical Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cannabinoid Derived Pharmaceutical Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Cannabinoid Receptor Type 1 (CB1)
Table 4. Major Players of Cannabinoid Receptor Type 2 (CB2)
Table 5. Major Players of Others
Table 6. Global Cannabinoid Derived Pharmaceutical Sales by Type (2018-2023) & (K Units)
Table 7. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2018-2023)
Table 8. Global Cannabinoid Derived Pharmaceutical Revenue by Type (2018-2023) & ($ million)
Table 9. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Type (2018-2023)
Table 10. Global Cannabinoid Derived Pharmaceutical Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Cannabinoid Derived Pharmaceutical Sales by Application (2018-2023) & (K Units)
Table 12. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2018-2023)
Table 13. Global Cannabinoid Derived Pharmaceutical Revenue by Application (2018-2023)
Table 14. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Application (2018-2023)
Table 15. Global Cannabinoid Derived Pharmaceutical Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Cannabinoid Derived Pharmaceutical Sales by Company (2018-2023) & (K Units)
Table 17. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Company (2018-2023)
Table 18. Global Cannabinoid Derived Pharmaceutical Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Company (2018-2023)
Table 20. Global Cannabinoid Derived Pharmaceutical Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Cannabinoid Derived Pharmaceutical Producing Area Distribution and Sales Area
Table 22. Players Cannabinoid Derived Pharmaceutical Products Offered
Table 23. Cannabinoid Derived Pharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cannabinoid Derived Pharmaceutical Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Cannabinoid Derived Pharmaceutical Sales Market Share Geographic Region (2018-2023)
Table 28. Global Cannabinoid Derived Pharmaceutical Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Cannabinoid Derived Pharmaceutical Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Country/Region (2018-2023)
Table 32. Global Cannabinoid Derived Pharmaceutical Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Cannabinoid Derived Pharmaceutical Sales by Country (2018-2023) & (K Units)
Table 35. Americas Cannabinoid Derived Pharmaceutical Sales Market Share by Country (2018-2023)
Table 36. Americas Cannabinoid Derived Pharmaceutical Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Cannabinoid Derived Pharmaceutical Revenue Market Share by Country (2018-2023)
Table 38. Americas Cannabinoid Derived Pharmaceutical Sales by Type (2018-2023) & (K Units)
Table 39. Americas Cannabinoid Derived Pharmaceutical Sales by Application (2018-2023) & (K Units)
Table 40. APAC Cannabinoid Derived Pharmaceutical Sales by Region (2018-2023) & (K Units)
Table 41. APAC Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2018-2023)
Table 42. APAC Cannabinoid Derived Pharmaceutical Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2018-2023)
Table 44. APAC Cannabinoid Derived Pharmaceutical Sales by Type (2018-2023) & (K Units)
Table 45. APAC Cannabinoid Derived Pharmaceutical Sales by Application (2018-2023) & (K Units)
Table 46. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2018-2023) & (K Units)
Table 47. Europe Cannabinoid Derived Pharmaceutical Sales Market Share by Country (2018-2023)
Table 48. Europe Cannabinoid Derived Pharmaceutical Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Cannabinoid Derived Pharmaceutical Revenue Market Share by Country (2018-2023)
Table 50. Europe Cannabinoid Derived Pharmaceutical Sales by Type (2018-2023) & (K Units)
Table 51. Europe Cannabinoid Derived Pharmaceutical Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Cannabinoid Derived Pharmaceutical Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Cannabinoid Derived Pharmaceutical Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Cannabinoid Derived Pharmaceutical
Table 59. Key Market Challenges & Risks of Cannabinoid Derived Pharmaceutical
Table 60. Key Industry Trends of Cannabinoid Derived Pharmaceutical
Table 61. Cannabinoid Derived Pharmaceutical Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Cannabinoid Derived Pharmaceutical Distributors List
Table 64. Cannabinoid Derived Pharmaceutical Customer List
Table 65. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Cannabinoid Derived Pharmaceutical Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Cannabinoid Derived Pharmaceutical Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Cannabinoid Derived Pharmaceutical Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Cannabinoid Derived Pharmaceutical Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Cannabinoid Derived Pharmaceutical Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Cannabinoid Derived Pharmaceutical Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Cannabinoid Derived Pharmaceutical Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Cannabinoid Derived Pharmaceutical Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Cara Therapeutics Inc Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 80. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 81. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Cara Therapeutics Inc Main Business
Table 83. Cara Therapeutics Inc Latest Developments
Table 84. Arena Pharmaceuticals Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 85. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 86. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Arena Pharmaceuticals Main Business
Table 88. Arena Pharmaceuticals Latest Developments
Table 89. Cannabics Pharmaceuticals Inc Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 90. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 91. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Cannabics Pharmaceuticals Inc Main Business
Table 93. Cannabics Pharmaceuticals Inc Latest Developments
Table 94. Echo Pharmaceuticals Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 95. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 96. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Echo Pharmaceuticals Main Business
Table 98. Echo Pharmaceuticals Latest Developments
Table 99. Gw Pharmaceuticals Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 100. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 101. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Gw Pharmaceuticals Main Business
Table 103. Gw Pharmaceuticals Latest Developments
Table 104. Inmed Pharmaceuticals Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 105. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 106. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Inmed Pharmaceuticals Main Business
Table 108. Inmed Pharmaceuticals Latest Developments
Table 109. Insys Therapeutics Inc Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 110. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 111. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Insys Therapeutics Inc Main Business
Table 113. Insys Therapeutics Inc Latest Developments
Table 114. Larapharm Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 115. Larapharm Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 116. Larapharm Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Larapharm Main Business
Table 118. Larapharm Latest Developments
Table 119. Mgc Pharmaceuticals Ltd Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 120. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 121. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Mgc Pharmaceuticals Ltd Main Business
Table 123. Mgc Pharmaceuticals Ltd Latest Developments
Table 124. One World Cannabis Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 125. One World Cannabis Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 126. One World Cannabis Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. One World Cannabis Main Business
Table 128. One World Cannabis Latest Developments
Table 129. Orpheus Medica Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 130. Orpheus Medica Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 131. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Orpheus Medica Main Business
Table 133. Orpheus Medica Latest Developments
Table 134. Receptor Life Sciences Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 135. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 136. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Receptor Life Sciences Main Business
Table 138. Receptor Life Sciences Latest Developments
Table 139. Respirerx Pharmaceuticals Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 140. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 141. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Respirerx Pharmaceuticals Main Business
Table 143. Respirerx Pharmaceuticals Latest Developments
Table 144. Tetra Bio-Pharma Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 145. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 146. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Tetra Bio-Pharma Main Business
Table 148. Tetra Bio-Pharma Latest Developments
Table 149. Cardiol Therapeutics Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 150. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 151. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Cardiol Therapeutics Main Business
Table 153. Cardiol Therapeutics Latest Developments
Table 154. United Cannabis Corporation Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 155. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 156. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. United Cannabis Corporation Main Business
Table 158. United Cannabis Corporation Latest Developments
Table 159. Zynerba Pharmaceuticals Basic Information, Cannabinoid Derived Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 160. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Portfolios and Specifications
Table 161. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Zynerba Pharmaceuticals Main Business
Table 163. Zynerba Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Cannabinoid Derived Pharmaceutical
Figure 2. Cannabinoid Derived Pharmaceutical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cannabinoid Derived Pharmaceutical Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Cannabinoid Derived Pharmaceutical Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cannabinoid Derived Pharmaceutical Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Cannabinoid Receptor Type 1 (CB1)
Figure 10. Product Picture of Cannabinoid Receptor Type 2 (CB2)
Figure 11. Product Picture of Others
Figure 12. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type in 2022
Figure 13. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Type (2018-2023)
Figure 14. Cannabinoid Derived Pharmaceutical Consumed in Epilepsy
Figure 15. Global Cannabinoid Derived Pharmaceutical Market: Epilepsy (2018-2023) & (K Units)
Figure 16. Cannabinoid Derived Pharmaceutical Consumed in Migraine
Figure 17. Global Cannabinoid Derived Pharmaceutical Market: Migraine (2018-2023) & (K Units)
Figure 18. Cannabinoid Derived Pharmaceutical Consumed in Multiple Sclerosis
Figure 19. Global Cannabinoid Derived Pharmaceutical Market: Multiple Sclerosis (2018-2023) & (K Units)
Figure 20. Cannabinoid Derived Pharmaceutical Consumed in Others
Figure 21. Global Cannabinoid Derived Pharmaceutical Market: Others (2018-2023) & (K Units)
Figure 22. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2022)
Figure 23. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Application in 2022
Figure 24. Cannabinoid Derived Pharmaceutical Sales Market by Company in 2022 (K Units)
Figure 25. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Company in 2022
Figure 26. Cannabinoid Derived Pharmaceutical Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Company in 2022
Figure 28. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Cannabinoid Derived Pharmaceutical Sales 2018-2023 (K Units)
Figure 31. Americas Cannabinoid Derived Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 32. APAC Cannabinoid Derived Pharmaceutical Sales 2018-2023 (K Units)
Figure 33. APAC Cannabinoid Derived Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 34. Europe Cannabinoid Derived Pharmaceutical Sales 2018-2023 (K Units)
Figure 35. Europe Cannabinoid Derived Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Cannabinoid Derived Pharmaceutical Revenue 2018-2023 ($ Millions)
Figure 38. Americas Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2022
Figure 39. Americas Cannabinoid Derived Pharmaceutical Revenue Market Share by Country in 2022
Figure 40. Americas Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 41. Americas Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 42. United States Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Cannabinoid Derived Pharmaceutical Sales Market Share by Region in 2022
Figure 47. APAC Cannabinoid Derived Pharmaceutical Revenue Market Share by Regions in 2022
Figure 48. APAC Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 49. APAC Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 50. China Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2022
Figure 58. Europe Cannabinoid Derived Pharmaceutical Revenue Market Share by Country in 2022
Figure 59. Europe Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 60. Europe Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 61. Germany Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Cannabinoid Derived Pharmaceutical Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2018-2023)
Figure 70. Egypt Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Cannabinoid Derived Pharmaceutical Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Cannabinoid Derived Pharmaceutical in 2022
Figure 76. Manufacturing Process Analysis of Cannabinoid Derived Pharmaceutical
Figure 77. Industry Chain Structure of Cannabinoid Derived Pharmaceutical
Figure 78. Channels of Distribution
Figure 79. Global Cannabinoid Derived Pharmaceutical Sales Market Forecast by Region (2024-2029)
Figure 80. Global Cannabinoid Derived Pharmaceutical Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Cannabinoid Derived Pharmaceutical Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Cannabinoid Derived Pharmaceutical Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Cannabinoid Derived Pharmaceutical Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Cannabinoid Derived Pharmaceutical Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
